Shefali Agarwal, Chief Medical Officer at Epizyme, Inc. (EPZM), sold 1,195 shares at $11.97 ($14K) on 2019-06-14, disclosed to the SEC on 2019-06-17.
Scheduled sale ($14k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| EPZM | SELL | 2022-02-09 | $2K | — | Filing → |
| EPZM | SELL | 2022-02-04 | $4K | — | Filing → |
| EPZM | SELL | 2022-01-28 | $6K | — | Filing → |